Bioavailability/Bioequivalence Strategies for MPTs – Feasibility and Risks 26 January 2017 This live webinar focused on critical conversations around bioavailability and bioequivalence strategies for MPTs, including feasibility and risks. The webinar featured a presentation by Charles DiLiberti of Montclair Bioequivalence Services and a facilitated discussion with Laneta Dorflinger of FHI 360 and Joseph Romano of […]